Search - tctmd.com

Displaying 141 - 160 of 261

Sort: Relevancy | Date

News Daily News

La Válvula Lotus Supera a la CoreValve en Algunos Indicadores en un Estudio No Aleatorizado de un Único Centro

L.A. McKeown

June 17, 2015

News Daily News

LV Flow After TAVR Predicts Late Mortality

June 11, 2015

Presentation TVT 2015

Case Presentation: Mild-Moderate Paravalvular Regurgitation During/After TAVR

Presenter: Antonio Colombo, A. Pieter Kappetein, Torsten P. Vahl

June 05, 2015

News Daily News

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

Yael L. Maxwell

June 03, 2015

News Daily News

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

Caitlin E. Cox

May 29, 2015

News Conference News EuroPCR 2015

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Yael L. Maxwell

May 22, 2015

News Conference News EuroPCR 2015

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Yael L. Maxwell

May 21, 2015

News Industry News

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

May 20, 2015

News Industry News

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

May 19, 2015

News Daily News

TAVR 后瓣周渗漏封堵能改善功能，但可能无法改善生存率

April 28, 2015

News Daily News

Post-TAVR Plugging of Paravalvular Leaks Improves Function But Probably Not Survival

April 28, 2015

News Daily News

El Taponamiento Post-TAVR de Fugas Paravalvulares Mejora la Función aunque Quizá No la Supervivencia

April 28, 2015

Presentation

Long-term Outcomes of Percutaneous Paravalvular Regurgitation Closure After TAVR

Presenter: Francesco Saia

April 27, 2015

News Daily News

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Caitlin E. Cox

April 17, 2015

News Daily News

Best Degree of Oversizing Varies by TAVR Device

Caitlin E. Cox

April 17, 2015

News Daily News

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Todd Neale

April 10, 2015

News Conference News ACC 2015

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Yael L. Maxwell

March 15, 2015

News Conference News ACC 2015

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

Todd Neale

March 15, 2015

News Daily News

PARTNER Analysis Looks at Predictors, Clinical Impact of Pacemaker Implantation

January 28, 2015

News Daily News

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

January 12, 2015

Advertisement

La Válvula Lotus Supera a la CoreValve en Algunos Indicadores en un Estudio No Aleatorizado de un Único Centro

LV Flow After TAVR Predicts Late Mortality

Case Presentation: Mild-Moderate Paravalvular Regurgitation During/After TAVR

Belgian Registry Reports Similar 3-Year Survival for Sapien, CoreValve in Transfemoral TAVR

EuroPCR 2015 Takes on TAVR, PCI Optimization, and More

New, Old CoreValve Iterations Showing Reductions in Pacemaker Need, Paravalvular Leak

Sapien 3 Experience in Europe, Canada Shows Low Mortality, Paravalvular Leak at 30 Days

Post-Market Study Evaluating The Boston Scientific Lotus™ Valve System Demonstrates Extremely Low PVL Rates

First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival And Low Stroke Rate

TAVR 后瓣周渗漏封堵能改善功能，但可能无法改善生存率

Post-TAVR Plugging of Paravalvular Leaks Improves Function But Probably Not Survival

El Taponamiento Post-TAVR de Fugas Paravalvulares Mejora la Función aunque Quizá No la Supervivencia

Long-term Outcomes of Percutaneous Paravalvular Regurgitation Closure After TAVR

El Mejor Grado de Sobredimensionamiento Varía en función del Dispositivo TAVR

Best Degree of Oversizing Varies by TAVR Device

After Propensity Matching, Early Mortality Risk Still Evident for Transapical TAVR

Thirty-day Outcomes with Sapien 3 Lowest Seen with Balloon-Expandable TAVR

Follow-up TAVR Studies Reassure About Valve Durability, Outcomes

PARTNER Analysis Looks at Predictors, Clinical Impact of Pacemaker Implantation

Many Heart Failure Patients Reap QoL Gain From TAVR Despite High Mortality

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content